International Cancer Conference Journal

, Volume 6, Issue 2, pp 76–79 | Cite as

Clinical features of 4 patients who underwent neoadjuvant chemotherapy for the locally advanced penile cancer

  • Yohei Matsuda
  • Naotaka Nishiyama
  • Tetsuya Shindo
  • Naoya Masumori
Case report


Of 32 patients with penile cancer who underwent medical treatment in our institute between 1999 and 2016, 4 with locally advanced penile cancer received penectomy, neoadjuvant chemotherapy, and lymphadenectomy for regional lymph node metastases. The median age and follow-up period were 46 years and 79 months. Clinical lymph node (N) stages cN1, cN2, and cN3 were observed in 1, 2, and 1 patient, respectively. Except for 1 patient who had partial penectomy, all received total penectomy for the primary tumors. All pathological findings were squamous cell carcinoma. Among the specimens at the time of the primary tumors, 1, 2, and 1 were classified as pT1, pT2, and pT3, respectively. Neoadjuvant chemotherapy composed of 5-fluorouracil and cisplatin in 2 cases and paclitaxel, ifosfamide, and cisplatin in 2 cases was performed for lymph node metastases. After chemotherapy, lymphadenectomy was performed for all patients and the pathological findings were pN0. During the follow-up period, all patients survived with no metastases and no recurrence.


Penile cancer Lymph node metastasis Neoadjuvant chemotherapy 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests.


  1. 1.
    Horenblas S (2001) Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 88:473–483CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRefPubMedGoogle Scholar
  3. 3.
    Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65:433–438CrossRefPubMedGoogle Scholar
  4. 4.
    Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147:630–632PubMedGoogle Scholar
  5. 5.
    Bermejo C, Busby JE, Spiess PE et al (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177:1335–1338CrossRefPubMedGoogle Scholar
  6. 6.
    Pagliaro LC, Williams DL, Daliani D et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28:3851–3857CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hitt R, López-Pousa A, Martínez-Trufero J et al (2005) Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23:8636–8645CrossRefPubMedGoogle Scholar
  8. 8.
    Pizzocaro G, Nicolai N, Milani A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55:546–551CrossRefPubMedGoogle Scholar
  9. 9.
    Djajadiningrat RS, Bergman AM, van Werkhoven E et al (2015) Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin Genitourin Cancer 13:44–49CrossRefPubMedGoogle Scholar

Copyright information

© The Japan Society of Clinical Oncology 2017

Authors and Affiliations

  1. 1.Department of Urology, School of MedicineSapporo Medical UniversitySapporoJapan

Personalised recommendations